Benefits of long-acting β2-agonists -: Reply

被引：0

|

作者：

Gibson, Peter G. ^{[1
]}

Ducharme, Francine M.

Cates, Christopher Joseph

机构：

[1] John Hunter Hosp, Newcastle, NSW, Australia

[2] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Montreal, PQ, Canada

[3] St Georges Univ London, London, England

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2007年 / 120卷 / 03期

关键词：

D O I：

10.1016/j.jaci.2007.04.043

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：726 / 726

页数：1

相关论文

共 50 条

[1] Benefits of long-acting β2-agonists
Lipworth, Brian J.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) : 725 - 725
[2] Safety Trials of Long-Acting β2-Agonists REPLY
Busse, William W.
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (15): : 1482 - 1482
[3] Pharmacogenomics of long-acting β2-agonists
Blake, Kathryn
Lima, John
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (11) : 1733 - 1751
[4] New long-acting β2-agonists
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (09) : 1385 - 1388
[5] Safety Trials of Long-Acting β2-Agonists
Weinberger, Miles
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (15): : 1481 - 1482
[6] Safety of long-acting β2-agonists in asthma
de Benedictis, Fernando Maria
Carloni, Ines
THORAX, 2012, 67 (11) : 1014 - U110
[7] Safety of long-acting β2-agonists in asthma
Rishton, Louise
LANCET RESPIRATORY MEDICINE, 2016, 4 (11): : 860 - 860
[8] Controversies regarding long-acting β2-agonists
Khianey, Reena
Oppenheimer, John
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (04) : 345 - 354
[9] Long-acting β2-agonists in asthma:: safety concerns
Wooltorton, E
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (09) : 1030 - 1031
[10] Long-acting inhaled β2-agonists in asthma therapy
Moore, RH
Khan, A
Dickey, BF
CHEST, 1998, 113 (04) : 1095 - 1108

← 1 2 3 4 5 →